M11.23
Other chondrocalcinosis, wrist
Clinical Classification Guidelines
Medical Intelligence & Overview
Chondrocalcinosis of the wrist, classified under ICD-10 code M11.23, is a condition characterized by the accumulation of calcium deposits within the cartilage of the wrist joints. This buildup can lead to joint pain, swelling, and reduced mobility. Also known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, this condition affects the cartilage tissue, causing it to harden and sometimes leading to arthritis-like symptoms. While the exact causes are not always clear, understanding the causes, symptoms, and available management options can help individuals affected by this condition.
Causes & Symptoms
Clinical Causes: Aging – the risk increases with advancing age due to changes in cartilage and calcium metabolism. Genetic predisposition – family history may increase susceptibility to joint calcification. Previous joint injuries or trauma – injury to the wrist can promote calcification. Metabolic disorders – conditions such as hyperparathyroidism, hemochromatosis, or hypophosphatasia may predispose individuals to CPPD crystal formation. Other underlying joint diseases – osteoarthritis or joint wear and tear can contribute to the development of chondrocalcinosis. Calcium and phosphate imbalances – disruptions in mineral metabolism can lead to abnormal calcium deposits. Certain medications – some drugs might influence calcium levels, although this is less common.
Key Symptoms: Joint pain – often persistent, especially during movement or after activity. Swelling around the wrist joint – due to inflammation caused by crystal deposits. Tenderness – when pressing on the affected area. Reduced range of motion – difficulty moving the wrist freely. Warmth and redness – signs of inflammation around the joint. Bursts of acute joint pain – episodes resembling gout but caused by calcium crystals. Possible formation of bony lumps or nodules near the joint.
Diagnostic & Treatment
Diagnosis Path: Diagnosing chondrocalcinosis of the wrist involves several steps. Medical professionals typically perform a physical examination to assess swelling, tenderness, and joint function. Imaging tests are crucial, with X-rays revealing characteristic calcium deposits within the cartilage of the wrist. In some cases, ultrasound may be used to evaluate joint inflammation and detect crystal deposits. To confirm the presence of CPPD crystals, a procedure called joint aspiration may be performed, where joint fluid is extracted and examined under a microscope for characteristic calcium pyrophosphate crystals. Laboratory tests might also be conducted to assess underlying metabolic conditions contributing to crystal formation.
Treatment Protocols: While there is no cure for chondrocalcinosis, treatment focuses on managing symptoms and improving joint function. Common approaches include: - Non-steroidal anti-inflammatory drugs (NSAIDs) – to reduce pain and inflammation. - Colchicine – often prescribed to prevent crystal-related attacks. - Corticosteroid injections – providing relief in cases of significant inflammation. - Physical therapy – to maintain joint mobility and strength. - Lifestyle modifications – including weight management and avoiding joint stress. - Managing underlying metabolic conditions – such as treating hyperparathyroidism or hemochromatosis to prevent progression. In severe cases, surgical interventions may be considered to remove calcium deposits or repair joint damage. Regular monitoring by healthcare providers is important to adjust treatments and prevent complications.
Clinical Advice & FAQs
Billing Guidance
Is M11.23 a billable ICD-10 code?
Yes, M11.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.23?
Clinical documentation must specify the nature of Other chondrocalcinosis, wrist and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
